(MedPage Today) — Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related macular degeneration (nAMD), according to a retrospective…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/115919
Author :
Publish date : 2025-06-05 15:48:00
Copyright for syndicated content belongs to the linked Source.
